索引超出了数组界限。
[1] 中华医学会急诊医学分会心脑血管病学组. 中国急诊急性心力衰竭单元建设与管理专家共识[J]. 中国急救医学, 2019, 39(6):532-537.
[2]Wang GH, Zheng XH, Zheng Y, et al. Construction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional genes in heart failure[J]. Mol Med Rep, 2019, 19(2):994-1003.
[3]Qu Q, Sun JY, Zhang ZY, et al. Hub microRNAs and genes in the development of atrial fibrillation identified by weighted gene co-expression network analysis[J]. BMC Med Genomics, 2021, 14(1):271.
[4] 廖江铨, 刘咏梅, 王阶. lncRNA与miRNA相互调控作用及与心血管疾病的关系[J]. 临床心血管病杂志, 2015, 31(3):234-237.
[5]Yu SY, Dong B, Zhou SH, et al. LncRNA UCA1 modulates cardiomyocyte apoptosis by targeting miR-143 in myocardial ischemia-reperfusion injury[J]. Int J Cardiol, 2017, 247:31.
[6]Gao RR, Wang LJ, Bei YH, et al. Long noncoding RNA cardiac physiological hypertrophy-associated regulator induces cardiac physiological hypertrophy and promotes functional recovery after myocardial ischemia-reperfusion injury[J]. Circulation, 2021, 144(4):303-317.
[7]Gao SJ, Ren SN, Liu YT, et al. Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis[J]. Mol Ther Oncolytics, 2021, 23:14-25.
[8]Aichen Z, Kun W, Xiaochun S, et al. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p[J]. Apoptosis, 2021, 26(5/6):348-360.
[9]Dong PX, Xiong Y, Yu JH, et al. Correction: control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in cervical cancer[J]. Oncogene, 2019, 38(20):3972-3972.
[10] 中国医师协会急诊医师分会, 中国心胸血管麻醉学会急救与复苏分会. 中国急性心力衰竭急诊临床实践指南(2017) [J]. 中华急诊医学杂志, 2017, 26(12):1347-1357.
[11] Mirzaei S, Zarrabi A, Asnaf SE, et al. The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators[J]. Life Sci, 2021, 268(2):119005.
[12] Zhang W, Dong YZ, Du X, et al. MiRNA-153-3p promotes gefitinib-sensitivity in non-small cell lung cancer by inhibiting ATG5 expression and autophagy[J]. Eur Rev Med Pharmacol Sci, 2019, 23(6):2444-2452.
[13] Villar AV, García R, Merino D, et al. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients[J]. Int J Cardiol, 2013, 167(6):2875-2881.
[14] Li Y, Sun GH, Wang LQ. MiR-21 participates in LPS-induced myocardial injury by targeting Bcl-2 and CDK6[J]. Inflammation Research, 2022, 71(2):205-214.
[15] Zhou F, Fu WD, Chen L. MiRNA-182 regulates the cardiomyocyte apoptosis in heart failure[J]. Eur Rev Med Pharmacol Sci, 2019, 23(11):4917-4923.
[16] Na JT, Jin HF, Wang X, et al. The crosstalk of HDAC3, microRNA-18a and ADRB3 in the progression of heart failure[J]. Cell Biosci, 2021, 11(1):31.
[17] 罗建华, 王超, 岳玉国. 老年急性心肌梗死患者血清miR-18a水平及意义[J]. 中国老年学杂志, 2019, 39(2):267-269.
[18] Wang J, Xin SB, Yang R, et al. Knockdown of lncRNA LUCAT1 attenuates sepsis induced myocardial cell injury by sponging miR-642a[J]. Mamm Genome, 2021, 32(6):457-465.
[19] Chen L, Yan KP, Liu XC, et al. Valsartan regulates TGF-β/Smads and TGF-β/p38 pathways through lncRNA CHRF to improve doxorubicin-induced heart failure[J]. Arch Pharm Res, 2018, 41(1):101-109.
[20] Sato M, Kadomatsu T, Miyata K, et al. The lncRNA caren antagonizes heart failure by inactivating DNA damage response and activating mitochondrial biogenesis[J]. Nat Commun, 2021, 12(1):2529.
[21] 孟晓京, 刘亚军, 项宁. lncRNA FGD5-AS1靶向miR-421对缺氧/复氧诱导的心肌细胞损伤的影响[J]. 山东医药, 2021, 61(16):30-34.